Hangzhou ConVerd Co., Ltd.
PrivateLast Round
Strategic
Sep 15, 2017
Total Funding Raised
$4.6M
Company Overview
Hangzhou ConVerd Co., Ltd. is a biotechnology company focused on the research and development of oncolytic viruses and other cancer immunotherapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou ConVerd Co., Ltd. Comparables
Compare Hangzhou ConVerd Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wuhan Binhui Biopharmaceutical Co., Ltd. | 88% | |
| Virogin Biotech | 84% | |
| ImmVira | 83% | |
Hangzhou ConVerd Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Sep 15, 2017 |
Hangzhou ConVerd Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Resources | Strategic |
| Morningside Group | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors grew 399% MoM.
- Nov 9, 2025
Monthly visitors increased 87% MoM.
Hangzhou ConVerd Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hangzhou ConVerd Co., Ltd.'s valuation, stock price, and market status.